Cooley advised Cardlytics on its $75.7 million initial public offering of 5,821,355 shares of common stock, including 421,355 shares sold pursuant to the partial exercise of…
Cardlytics’ $76 Million Initial Public Offering
Cooley advised Cardlytics on its $75.7 million initial public offering of 5,821,355 shares of common stock, including 421,355 shares sold pursuant to the partial exercise of…